Perceptive Advisors - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 149 filers reported holding REATA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$68,334,204
-65.4%
670,206
-69.1%
1.98%
-66.0%
Q1 2023$197,230,574
+7748.4%
2,169,276
+2069.3%
5.82%
+7876.7%
Q3 2022$2,513,000
+72.5%
100,000
+124.8%
0.07%
+151.7%
Q1 2022$1,457,000
+84.2%
44,475
+359.6%
0.03%
+38.1%
Q3 2018$791,0009,6770.02%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
CPMG Inc 3,023,349$285,253,00033.71%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 245,000$23,116,00017.80%
Prosight Management, LP 124,965$11,790,0005.94%
Cormorant Asset Management, LP 806,150$76,060,0004.37%
LBJ Family Wealth Advisors, Ltd. 44,096$3,710,0002.74%
MORGENS WATERFALL VINTIADIS & CO INC 34,350$3,241,0002.23%
Biondo Investment Advisors, LLC 73,090$6,896,0001.64%
P.A.W. CAPITAL CORP 15,000$1,415,0001.53%
EMERALD ADVISERS, LLC 387,369$36,548,0001.47%
SPHERA FUNDS MANAGEMENT LTD. 112,769$10,640,0001.46%
View complete list of REATA PHARMACEUTICALS INC shareholders